A September to Remember - Aflac's Bridge to Brighter Campaign Illuminates Company's Ongoing Support for Children with Cancer and Sickle Cell Disease
Program Shines a Light on Childhood Cancer and Sickle Cell Disease during National Childhood Cancer and National Sickle Cell Awareness month and beyond
COLUMBUS, Ga., October 26, 2023 /3BL/ -- Aflac, a leading provider of supplemental health insurance products in the U.S. and a proud supporter of families of children with cancer and blood disorders such as sickle cell disease, recently announced the culmination of its campaign to illuminate bridges and other landmarks across the country to commemorate National Childhood Cancer Awareness Month and National Sickle Cell Awareness Month. Aflac, a pioneer in cancer insurance coverage, has supported childhood cancer initiatives since 1995, having contributed more than $170 million to the cause.
Throughout the month of September, bridges in Atlanta, GA; Buffalo, NY; Fort Wayne, IN; Nashville, TN; Minneapolis, MN; and other U.S. cities were lit by Aflac in gold and burgundy – the recognition colors for childhood cancer and sickle cell disease – in support of the children and families who show incredible courage in the face of life-altering diagnoses.
"For nearly three decades, Aflac has been committed to supporting medical professionals, nonprofit organizations, family members and others who care for children with cancer and blood disorders like sickle cell disease," Aflac U.S. President Virgil R. Miller said. "Bridge to Brighter is an extension of Aflac's core company mission to bridge the gap for people and communities when they need us the most."
The bridge lightings are an expression of Aflac's Bridge to Brighter campaign, a monthlong effort to shine a bright light helping Americans to learn more about childhood cancer and sickle cell disease and how they can get involved to make a difference. In early September, Aflac launched a digital destination, The Bridge to Brighter, where visitors can hear and read stories about childhood cancer and sickle cell, spread the word to their communities, and ultimately take action, such as by registering as a bone marrow donor or making donations to the Aflac Cancer Center at give.choa.org.
Primary sponsor of the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, much of the $170 million in financial support comes from independent sales agents and Aflac employees. Additionally, in 2018, Aflac created My Special Aflac Duck, a robotic companion that provides comfort and support to children, helps them express their emotions, and normalizes medical procedures. Over the past five years, Aflac has distributed more than 24,000 of these ducks free of charge to children above the age of three with cancer and sickle cell disease.
ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than 67 years to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance policies in force. In 2021, the company became a signatory of the Principles for Responsible Investment (PRI). In 2022, the company was included in the Dow Jones Sustainability North America Index for the ninth year, the World's Most Ethical Companies by Ethisphere for the 17th consecutive year, Fortune's World's Most Admired Companies for the 22nd time and Bloomberg's Gender-Equality Index for the fourth consecutive year. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."
1 LIMRA 2021 US Supplemental Health Insurance Total Market Report
Media contact for Aflac: Jon Sullivan, 706-763-4813 or email@example.com
Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or firstname.lastname@example.org